Seeking Alpha

Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy

TAMPA, Fla., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (PCRX),, the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced ...
Healio

Nerve blocks placed with ultrasound guidance yield 99% success rate

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio VANCOUVER, British Columbia — Using ...
Healio

Ultrasound guidance for sciatic nerve blocks shown to have a 99% success rate

Please provide your email address to receive an email when new articles are posted on . VANCOUVER, British Columbia — Recent research indicates that using ultrasound guidance for the placement of ...
Yahoo Finance

Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Sciatic Nerve Block in the Popliteal Fossa for Bunionectomy

TAMPA, Fla., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today ...
Nasdaq

Pacira's (PCRX) Label Expansion Study on Exparel Meets Goal

Pacira BioSciences, Inc. PCRX announced positive top-line data from a phase III study evaluating its marketed drug, Exparel, as a single-dose sciatic nerve block in the popliteal fossa for ...